Czech
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

galactose/rakovina

Odkaz je uložen do schránky
13 Výsledek
TECHNICAL SECTOR The present invention is related with the field of immunology and human medicine particularly with the generation and selection of a monoclonal antibody (Mab) against the N-glycolylated-galactose-glucose sialic acid olygosaccharide sequence that can be used for the diagnosis and

Biomarker for detecting cancer

Články mohou překládat pouze registrovaní uživatelé
Přihlášení Registrace
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates generally to the field of molecular biology, immunology and oncology. More particularly, it concerns methods for detecting biomarkers linked to the development of cancer. 2. Description of Related Art Modern medicine

Biomarker for detecting cancer

Články mohou překládat pouze registrovaní uživatelé
Přihlášení Registrace
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates generally to the field of molecular biology, immunology and oncology. More particularly, it concerns methods for detecting biomarkers linked to the development of cancer. 2. Description of Related Art Modern medicine

Screening test for early detection of colorectal cancer

Články mohou překládat pouze registrovaní uživatelé
Přihlášení Registrace
FIELD OF THE INVENTION This invention relates to a simple screening test for colorectal cancer whereby a marker is detected in rectal mucus. More particularly, this marker is detected in the mucus deposited on a support using Schiff's reagent. BACKGROUND OF THE INVENTION Colorectal carcinoma is the

Iodo-hexose compounds useful to treat cancer

Články mohou překládat pouze registrovaní uživatelé
Přihlášení Registrace
BACKGROUND Cancer treatment regimens are frequently challenged by multi-drug resistance as tumor cells adapt in response to drug treatment. Apoptosis, a type of programmed cell death, involves a series of biochemical events that lead to changes in cell morphology and death. The apoptotic process is

Tumor lesion regression and conversion in situ into autologous tumor vaccines by compositions that result in anti-Gal antibody binding

Články mohou překládat pouze registrovaní uživatelé
Přihlášení Registrace
FIELD OF INVENTION The present invention is related to the field of cancer treatment. In one embodiment, the invention contemplates administering compounds to tumor lesions that induce local expression of .alpha.-gal epitopes within the tumor. In one embodiment, the administration induces regression

Screening test for large intestinal cancer

Články mohou překládat pouze registrovaní uživatelé
Přihlášení Registrace
DESCRIPTION OF THE INVENTION 1. Technical Field of the Invention This invention relates to a screening test for large intestinal cancer by detecting the presence of the disaccharide .beta.-D-Gal-(1->>3)-D-GalNAc in large intestinal mucus. 2. Background Art Cancer of the colon, cecum, and

Bifunctional glycoproteins having a modified carbohydrate complement and their use in tumor-selective therapy

Články mohou překládat pouze registrovaní uživatelé
Přihlášení Registrace
BACKGROUND OF THE INVENTION 1. Field of the Invention The invention relates to bifunctional glycoproteins having targeting protein and enzyme properties. More particularly, the invention relates to such proteins whose complements of carbohydrate residues have been modified in a manner that enhances

Synthetic glycoamines and methods for their use that affect cell adhesion, inhibit cancer cell metastasis, and induce apoptosis

Články mohou překládat pouze registrovaní uživatelé
Přihlášení Registrace
FIELD OF THE INVENTION The present invention relates to pharmaceuticals that affect cell adhesion, inhibit cancer cell metastasis, and induce apoptosis both in vitro and in vivo. Background of the Invention Cell adhesion is one important property that differentiates multi-cellular organisms from

Human B-lymphoblastoid cell line secreting anti-ganglioside antibody

Články mohou překládat pouze registrovaní uživatelé
Přihlášení Registrace
BACKGROUND OF THE INVENTION This invention was made with Government support under Grant Nos. CA 30647, CA 42396 and CA 12582 awarded by the National Cancer Institute. 1. Field of the Invention The present invention relates generally to Epstein-Barr virus-transformed human B-lymphoblastoid cell

Monoclonal antibodies that bind to alpha-acid glycoprotein

Články mohou překládat pouze registrovaní uživatelé
Přihlášení Registrace
This invention relates to a monoclonal antibody and a method for the production thereof. More particularly, it relates to a monoclonal antibody specific for a .alpha..sub.1 -acid glycoprotein or specific for at least one antigenic determinant included in a sugar chain of the following formula which

Method for the analysis of N-glycans attached to immunoglobulin G from human blood plasma and its use

Články mohou překládat pouze registrovaní uživatelé
Přihlášení Registrace
CROSS REFERENCE TO RELATED APPLICATIONS This application is the U.S. National Phase Application of PCT/HR2014/000022, filed Jun. 11, 2014, which claims priority to Croatian Patent Application No. P20130568A, filed Jun. 20, 2013, the contents of such applications being incorporated by reference

Methods of screening for agonists and antagonists of the interaction between the human KIAA0001 receptor and ligands thereof

Články mohou překládat pouze registrovaní uživatelé
Přihlášení Registrace
FIELD OF THE INVENTION This invention relates to methods for discovering agonists and antagonists of the interaction between UDP-sugars (e.g.,UDP-glucose, UDP-galactose, UDP-glucuronic acid, and UDP-N-acetyl glucosamine) and their cellular receptor, human KIAA0001 receptor. The invention also
Připojte se k naší
facebookové stránce

Nejúplnější databáze léčivých bylin podložená vědou

  • Funguje v 55 jazycích
  • Bylinné léky podporované vědou
  • Rozpoznávání bylin podle obrázku
  • Interaktivní mapa GPS - označte byliny na místě (již brzy)
  • Přečtěte si vědecké publikace související s vaším hledáním
  • Hledejte léčivé byliny podle jejich účinků
  • Uspořádejte své zájmy a držte krok s novinkami, klinickými testy a patenty

Zadejte symptom nebo chorobu a přečtěte si o bylinách, které by vám mohly pomoci, napište bylinu a podívejte se na nemoci a příznaky, proti kterým se používá.
* Všechny informace vycházejí z publikovaného vědeckého výzkumu

Google Play badgeApp Store badge